Anplag

DRUG3 trials

Sponsors

Alvogen Korea, Korea United Pharm. Inc.

Conditions

Healthy

Phase 1

Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers

CompletedNCT01421563

Alvogen KoreaHealthy

Start: 2011-02-28End: 2011-02-28Updated: 2011-08-23

Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy Volunteers

CompletedNCT01429688

Alvogen KoreaHealthy

Start: 2011-07-31End: 2011-08-31Updated: 2011-09-07

Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation

CompletedNCT01841086

Korea United Pharm. Inc.Healthy

Start: 2011-09-30End: 2011-12-31Updated: 2013-04-26